New drugs on the PBS: what they do and why we need them

The Conversation, 4 May 2017
Author: Nial Wheate
“This week, the government announced the latest additions, amendments, and deletions from the Pharmaceutical Benefits Scheme (PBS): the program through which essential medicines are subsidised for Australian patients. Listing on the PBS is different to a drug being approved for sale by Australia’s drug regulator. Once approved by the TGA, it is available to patients and hospitals at the full price. It only becomes subsidised if later listed on the PBS. Some of the notable additions to the list include drugs to treat eye infections, human immunodeficiency virus (HIV), cystic fibrosis, multiple sclerosis, cancer, and idiopathic pulmonary fibrosis.”
Find article here.